⚕ GalenOps CRO console
← 710 (USA)

710-1070

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 710 (USA) (Dr. Silva) · consented 2012-09-08
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-12 (study day 96.0); relationship: PROBABLE

severe assessed 2026-08-18

Severe GASTROINTESTINAL HAEMORRHAGE — outcome: RECOVERED/RESOLVED; onset 2013-02-05 (study day 151.0); relationship: NONE; serious criteria: hospitalization

severe assessed 2026-08-18

Severe HIP FRACTURE — outcome: RECOVERED/RESOLVED; onset 2013-01-22 (study day 137.0); relationship: NONE; serious criteria: hospitalization

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-12 (study day 96.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-12 (study day 96.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild SUPRAVENTRICULAR EXTRASYSTOLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-10-06 (study day 29.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.